DMC Group, LLC

Position in LLY — ELI LILLY & Co

CIK 1893403 BIRMINGHAM, AL

Position in LLY

as of Jun 30, 2026 · filed Jul 28, 2026 Compact

Position Value

$381,418

-$65,590 QoQ

Shares Held

318

-34.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#3,973

of 4,605 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DMC Group, LLC holds $5,256,393 across 6 Drug Manufacturers - General names. LLY ranks #4 (7.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	11,396	$1,439,770
2	ABBV	AbbVie Inc.	5,543	$1,394,840
3	AMGN	Amgen Inc	3,644	$1,319,565
4	LLY	ELI LILLY & Co This page	318	$381,418
5	MRK	Merck & Co., Inc.	2,940	$377,790
6	NVO	Novo Nordisk A S	7,155	$343,010

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$381,418	318	-34.6%	Shares	Sole	2026-07-28
2026-03-31	$447,008	486	-24.3%	Shares	Sole	2026-04-30
2025-12-31	$689,944	642	-12.7%	Shares	Sole	2026-01-21
2025-09-30	$560,805	735	+4.0%	Shares	Sole	2025-10-29
2025-06-30	$551,127	707	-8.4%	Shares	Sole	2025-07-23
2025-03-31	$637,602	772	-7.2%	Shares	Sole	2025-04-30
2024-12-31	$642,304	832	-22.5%	Shares	Sole	2025-01-23
2024-09-30	$951,499	1,074	-11.8%	Shares	Sole	2024-10-18
2024-06-30	$1,101,847	1,217	-19.7%	Shares	Sole	2024-07-16
2024-03-31	$1,178,609	1,515	-0.3%	Shares	Sole	2024-04-19
2023-12-31	$886,038	1,520	-14.1%	Shares	Sole	2024-01-10
2023-09-30	$950,720	1,770	-13.5%	Shares	Sole	2023-10-26
2023-06-30	$959,533	2,046	-4.7%	Shares	Sole	2023-07-13
2023-03-31	$737,322	2,147	-2.7%	Shares	Sole	2023-04-24
2022-12-31	$807,408	2,207	-3.5%	Shares	Sole	2023-02-07
2022-09-30	$739,501	2,287	-10.2%	Shares	Sole	2022-10-27
2022-06-30	$826,138	2,548	+13.2%	Shares	Sole	2022-08-09
2022-03-31	$644,332	2,250	-21.7%	Shares	Sole	2022-04-25
2021-12-31	$793,856	2,874	—	Shares	Sole	2022-01-31
No filing history on record for this holder in this stock.